Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: A prospective sequential comparison

被引:81
作者
Bayer, Ole [1 ]
Reinhart, Konrad [1 ]
Sakr, Yasser [1 ]
Kabisch, Bjoern
Kohl, Matthias [1 ]
Riedemann, Niels C. [1 ]
Bauer, Michael [1 ]
Settmacher, Utz [2 ]
Hekmat, Khosro [3 ]
Hartog, Christiane S. [1 ]
机构
[1] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany
[2] Jena Univ Hosp, Dept Gen Visceral & Vasc Surg, Jena, Germany
[3] Jena Univ Hosp, Dept Cardiothorac Surg, Jena, Germany
关键词
plasma substitutes; severe sepsis; hydroxyethyl starch; gelatin; crystalloids; acute renal failure; CRITICALLY-ILL PATIENTS; ACUTE KIDNEY INJURY; HYDROXYETHYL STARCH; PULMONARY PERMEABILITY; RESUSCITATION; THERAPY; SALINE; GELATIN; VOLUME; GUIDELINES;
D O I
10.1097/CCM.0b013e318212096a
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: Hydroxyethyl starch 200 is associated with renal impairment in sepsis, but hydroxyethyl starch 130/0.4 and gelatin are considered to be less harmful. We hypothesized that fluid therapy with only crystalloids would decrease the incidence of acute kidney injury. Design: Prospective sequential comparison during intensive care unit stay. Setting: Surgical intensive care unit. Patients: Patients with severe sepsis. Interventions: Changes in standard fluid therapy, with predominantly 6% hydroxyethyl starch from January 2005 to June 2005, 4% gelatin from January 2006 to June 2006, and only crystalloids from September 2008 to June 2009. Measurements and Main Results: Acute kidney injury was defined by the presence of at least one RIFLE class; 118 patients received hydroxyethyl starch, 87 patients received gelatin, 141 patients received only crystalloids. Baseline serum creatinine values were similar. Patients received median cumulative doses of 46 (interquartile range, 18-92) mL/kg hydroxyethyl starch and 43 (interquartile range, 18-76) mL/kg gelatin. Total median fluid amounts were 649 (interquartile range, 275-1098) mL/kg in the hydroxyethyl starch group, 525 (237-868) mL/kg in the gelatin group, and 355 (173-911) mL/kg in the crystalloid group. The difference was statistically significant for hydroxyethyl starch after adjustment for multiple testing. Mean daily fluid intake and fluid balance were higher on days 0 and 1 in the crystalloid group. Acute kidney injury occurred in 70% of patients receiving hydroxyethyl starch (adjusted p = .002) and in 68% of patients receiving gelatin (adjusted p = .025) vs. 47% patients receiving crystalloids. Need for renal replacement therapy tended to be higher in the hydroxyethyl starch group (34%; adjusted p = .086) and in the gelatin group (34%; adjusted p = .162) in comparison to the crystalloid group (20%). Intensive care unit and hospital mortality were similar in each group (hydroxyethyl starch: 35% and 43%; gelatin: 26% and 31%; crystalloids: 30% and 37%). Conclusion: Fluid resuscitation with only crystalloids was equally effective, resulted in a more positive fluid balance only on the first 2 days, and was associated with a lesser incidence of acute kidney injury. (Crit Care Med 2011; 39:1335-1342)
引用
收藏
页码:1335 / 1342
页数:8
相关论文
共 38 条
  • [1] [Anonymous], COCHRANE DATABASE SY
  • [2] A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients
    Bagshaw, Sean M.
    George, Carol
    Bellomo, Rinaldo
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (05) : 1569 - 1574
  • [3] Basora M, 2007, Rev Esp Anestesiol Reanim, V54, P162
  • [4] Promoting Global Research Excellence in Severe Sepsis (PROGRESS): Lessons from an International Sepsis Registry
    Beale, R.
    Reinhart, K.
    Brunkhorst, F. M.
    Dobb, G.
    Levy, M.
    Martin, G.
    Martin, C.
    Ramsey, G.
    Silva, E.
    Vallet, B.
    Vincent, J. -L.
    Janes, J. M.
    Sarwat, S.
    Williams, M. D.
    [J]. INFECTION, 2009, 37 (03) : 222 - 232
  • [5] RETRACTED: PRO: hydroxyethylstarch can be safely used in the intensive care patient-the renal debate (Retracted Article)
    Boldt, Joachim
    [J]. INTENSIVE CARE MEDICINE, 2009, 35 (08) : 1331 - 1336
  • [6] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [7] Pruritus precipitated by hydroxyethyl starch: a review
    Bork, K
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (01) : 3 - 12
  • [8] Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury
    Boussekey, Nicolas
    Darmon, Raphael
    Langlois, Joachim
    Alfandari, Serge
    Devos, Patrick
    Meybeck, Agnes
    Chiche, Arnaud
    Georges, Hugues
    Leroy, Olivier
    [J]. CRITICAL CARE, 2010, 14 (02):
  • [9] Intensive insulin therapy and pentastarch resuscitation in severe sepsis
    Brunkhorst, Frank M.
    Engel, Christoph
    Bloos, Frank
    Meier-Hellmann, Andreas
    Ragaller, Max
    Weiler, Norbert
    Moerer, Onnen
    Gruendling, Matthias
    Oppert, Michael
    Grond, Stefan
    Olthoff, Derk
    Jaschinski, Ulrich
    John, Stefan
    Rossaint, Rolf
    Welte, Tobias
    Schaefer, Martin
    Kern, Peter
    Kuhnt, Evelyn
    Kiehntopf, Michael
    Hartog, Christiane
    Natanson, Charles
    Loeffler, Markus
    Reinhart, Konrad
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (02) : 125 - 139
  • [10] Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients
    Cittanova, ML
    Leblanc, I
    Legendre, C
    Mouquet, C
    Riou, B
    Coriat, P
    [J]. LANCET, 1996, 348 (9042) : 1620 - 1622